Last updated 2026-06-18
- Acquired by United Therapeutics Corporation, Apr 2018
- Raised $30M funding round, Apr 2017
- Raised $32M funding round, Jul 2016
Total raised
$126.6M
Last: 2017-04
Stage
Acquired
Founded
2005
Headcount
8
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
SteadyMed Therapeutics Inc has developed the PatchPump platform to deliver injectable drugs. Using its proprietary ECell technology, the PatchPump is a customizable, prefilled, preprogrammed disposable parenteral (non-oral) delivery platform for large-volume and viscous formulations. The device attaches to the abdomen and delivers medicine through a small needle on an ongoing basis. SteadyMed's product will initially be focused on serving patients with pulmonary arterial hypertension and chronic pain.
Funding history · 6 rounds · $126.6M total
2016-07
2015-01
2013-04
$3.0M
2012-09
2009-01
$2.0M
Q&A
- What is SteadyMed Therapeutics' primary product or platform?
- SteadyMed Therapeutics has developed the PatchPump platform, which is a customizable, prefilled, preprogrammed disposable parenteral delivery device for injectable drugs, utilizing its proprietary ECell technology.
- What medical conditions is SteadyMed Therapeutics' product initially focused on addressing?
- SteadyMed Therapeutics' product is initially focused on serving patients with pulmonary arterial hypertension and chronic pain.
- When was SteadyMed Therapeutics founded?
- SteadyMed Therapeutics was founded in June 2005.
- How many employees does SteadyMed Therapeutics have?
- SteadyMed Therapeutics has 1-10 employees.
- What is the total amount of funding raised by SteadyMed Therapeutics?
- SteadyMed Therapeutics has raised a total of $126.6 million USD.
- When was SteadyMed Therapeutics acquired and by whom?
- SteadyMed Therapeutics was acquired by United Therapeutics Corporation in April 2018.
- Which investors participated in SteadyMed Therapeutics' July 2016 funding round?
- In July 2016, SteadyMed Therapeutics received funding from OrbiMed.
- Which investors participated in SteadyMed Therapeutics' April 2017 funding round?
- In April 2017, SteadyMed Therapeutics received funding from Adage Capital Management and OrbiMed.
- Where is SteadyMed Therapeutics headquartered?
- SteadyMed Therapeutics is headquartered in Rehovot, Center District, Israel.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Sensing
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2CB2B
Tags
cardiovascularpulmonarymedical-technologiesdrug-deliverypharmaceuticalspumpsblood-pressuresensorspharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/3176521 |
Identifiers & details
| Founded | 2005-6 |
|---|---|
| Employees (exact) | 8 |
| Offices | USA |
| Status reason | Acquired (Inactive) by United Therapeutics Corporation on Apr 2018 - closed due to acquisition |
Acquisitions & public offerings
Acquired by United Therapeutics Corporation 2018-04
Radar intelligence
Patents
| EPO | 4 |
|---|